Non-Small Cell Lung Cancer (NSCLC): Treatment Guide

Non small cell lung cancer (NSCLC) accounts for about 85% of all lung cancers diagnosed globally every year, affecting millions of lives, including many in India. Early and expert intervention can dramatically improve survival and quality of life, but choosing the right care—and the right expert—can make all the difference. Dr Mathangi, Senior Radiation Oncologist at Gleneagles Cancer Institute, Bangalore, brings over 20 years of pioneering expertise to guide you through the most advanced, compassionate, and effective NSCLC care available today.

What is non small cell lung cancer?

Non small cell lung cancer is a group of lung cancers that behave similarly and are distinct from small cell lung cancer. It includes several subtypes, primarily adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. NSCLC typically grows and spreads more slowly than small cell lung cancer, but its impact is profound due to late diagnosis in many patients.

How is NSCLC lung cancer diagnosed?

Accurate diagnosis is the foundation for effective lung cancer treatment. NSCLC lung cancer is typically detected through a combination of:

• Imaging tests (CT scan, PET-CT, chest X-ray)
• Biopsy (bronchoscopy, CT-guided biopsy, or surgical sampling)
• Molecular and genetic testing for actionable mutations

Early symptoms may include persistent cough, chest pain, shortness of breath, and unexplained weight loss. However, many cases are uncovered during investigation for unrelated symptoms.

Types and stages of non small lung cancer

Non small lung cancer is not a single disease but a spectrum involving various histological types:

• Adenocarcinoma (most common, especially in non-smokers)
• Squamous cell carcinoma
• Large cell carcinoma
• Non squamous lung cancer (an umbrella term for adenocarcinoma and large cell carcinoma, excluding squamous subtype)

Staging is critical for selecting the most appropriate therapy. The main stages include:

Stage	Description	Treatment Approach
Stage 1 NSCLC	Tumor confined to the lung, no lymph nodes involved	Surgery, sometimes followed by adjuvant therapy
Stage 3 NSCLC	Larger tumor/multiple lymph nodes, but no distant spread	Combination of chemotherapy, radiation therapy, and possibly surgery
Stage 4 NSCLC	Cancer has spread to distant organs (metastatic)	Systemic therapy (immunotherapy, targeted therapy, chemo), palliative care

The importance of early detection and staging in NSCLC

Prompt diagnosis and accurate staging of non small cell lung cancer are vital as they significantly influence survival rates and therapeutic options. For example, patients with stage 1 NSCLC may achieve cure with surgery and focused radiation therapy, while those with stage 4 NSCLC benefit from personalized systemic treatments to extend life and manage symptoms.

Personalizing lung cancer treatment

Every patient’s journey with NSCLC lung cancer is unique. At Gleneagles Cancer Institute, Dr Mathangi leads a multidisciplinary team that tailors each lung cancer treatment plan based on:

• Cancer stage and subtype (e.g., non squamous lung cancer)
• Molecular and genetic profiles (EGFR, ALK, ROS1, PD-L1 status)
• Patient’s age, overall health, and preferences
• Symptom burden and tumor location

This personalized approach ensures maximum effectiveness with minimal side effects, leveraging the latest advances in oncology.

Main treatment options for non small cell lung cancer

The treatment landscape for non small lung cancer is constantly evolving, thanks to ongoing research and technological improvements. Major treatment options include:

• Surgery: Best for early-stage (stage 1 NSCLC), involves removing the tumor and nearby tissues.
• Radiation therapy: State-of-the-art techniques like Stereotactic Ablative Body Radiotherapy (SBRT), Gated RapidArc, DIBH gated radiotherapy, and image-guided interstitial brachytherapy are available under Dr Mathangi’s care. Radiation therapy is crucial for inoperable tumors, locally advanced disease, and palliation in advanced stages.
• Chemotherapy: Drugs to destroy cancer cells, often combined with radiation or surgery.
• Targeted therapy: For patients with specific genetic mutations (like EGFR, ALK, ROS1).
• Immunotherapy: Harnesses the patient’s immune system to fight cancer, especially effective in stage 4 NSCLC with high PD-L1 expression.
• Supportive and palliative care: For symptom relief and quality of life improvement at any stage.

Role of advanced radiation therapy in NSCLC

Radiation therapy has revolutionized the management of non small cell lung cancer. Under the guidance of Dr Mathangi, Gleneagles Cancer Institute offers precision techniques such as:

• Stereotactic Ablative Body Radiotherapy (SBRT): Delivers high-dose radiation with pinpoint accuracy, ideal for small, early-stage tumors and patients unfit for surgery.
• Gated RapidArc and DIBH: Allow real-time tracking of tumor motion (e.g., breathing), minimizing side effects to healthy lung, heart, and tissues.
• Image-Guided Interstitial Brachytherapy: Places radiation sources directly into/near the tumor, boosting local control in selected cases.

These techniques maximize tumor destruction while sparing healthy organs, reducing treatment time and improving patient comfort.

Latest advances in non squamous lung cancer care

Non squamous lung cancer patients can benefit from exciting advances, including:

• Personalized molecular profiling for targeted therapies
• Immunotherapy options that harness your body’s natural defenses
• Minimally invasive surgery and SBRT for early-stage disease
• Combination therapies for complex and advanced cases

Dr Mathangi’s team ensures you have access to the latest protocols and clinical trials where appropriate, maximizing your chance of remission or long-term control.

Accessing expert lung cancer treatment in India

Accessing world-class lung cancer treatment is simpler than ever. At Gleneagles Cancer Institute, Bangalore, Dr Mathangi’s team offers comprehensive evaluation, advanced imaging, personalized planning, and ongoing support—all under one roof.

• Comprehensive diagnostics and staging
• Multidisciplinary tumor board discussions
• Patient-centric, evidence-based care plans
• State-of-the-art technology across all stages (including stage 1 NSCLC, stage 3 NSCLC, and stage 4 NSCLC)

For those in South India, North India, or across the country, you can easily reach Dr Mathangi’s team for a second opinion or complete care pathway.

Reasons to choose Dr Mathangi for non small cell lung cancer care

• Unmatched expertise in advanced radiation therapy
• 20+ years of leadership in cancer care
• Compassionate, personalized treatment for every patient
• Access to cutting-edge technology and clinical research
• Trusted by thousands of patients for lung and other complex cancers

Choosing the right oncologist isn’t just about credentials—it’s about confidence in your care, peace of mind for your family, and the best possible chance for recovery.

Cancers commonly treated with radiation therapy

According to Dr Mathangi, radiation therapy is a pivotal modality for many cancers, including:

• Head and neck cancers
• Brain tumors and spine tumors
• Esophagus, rectal, and lung cancers
• Liver, bladder, prostate, uterine, cervical, vulval, anal canal, and penile cancers
• Breast cancers

This multi-cancer expertise ensures that patients with non small cell lung cancer receive truly comprehensive, integrated care.

About Dr Mathangi

Dr Mathangi J is a distinguished Senior Radiation Oncologist and the In-charge at Gleneagles Cancer Institute, Bangalore. With a track record of installing Asia Pacific’s first TrueBeam STx Machine and treating over 12,000 patients, she is a national leader in advanced radiotherapy. Her special focus on lung, head and neck, brain, prostate, and women’s cancers is complemented by international training in Stereotactic Ablative Body Radiotherapy (SBRT), Gated RapidArc, DIBH, and brachytherapy techniques. Dr Mathangi is also the Director of Fellowship in Advanced Radiotherapy techniques (RGUHS), shaping the next generation of cancer specialists in India.

For more about her work, visit drmathangi.com, or follow her on Facebook and Instagram.

Frequently Asked Questions

What is non small cell lung cancer (NSCLC) and how is it different from other types of lung cancer?

Non small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for about 85% of all cases. Unlike small cell lung cancer, NSCLC tends to grow and spread more slowly. NSCLC is further divided into subtypes, including adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Dr. Mathangi specializes in personalized evaluation and treatment approaches for NSCLC, helping patients understand their diagnosis and the best treatment options for their specific subtype.

What are the main treatment options for NSCLC lung cancer?

The primary lung cancer treatment options for NSCLC lung cancer include surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy. The choice of treatment depends on the stage and type of NSCLC, as well as the patient's overall health. Dr. Mathangi provides comprehensive care, guiding patients through all available treatments and helping select the most effective and least invasive approach whenever possible.

How is stage 1 NSCLC typically managed?

Stage 1 NSCLC is generally localized and has not spread beyond the lung. Treatment often involves surgical removal of the tumor, sometimes followed by radiation therapy if surgery is not suitable or if there are high-risk features. Dr. Mathangi ensures a detailed evaluation and discusses all options, including less invasive procedures and advanced radiation techniques, to maximize the chances of cure with minimal side effects.

What are the treatment strategies for stage 3 NSCLC?

Stage 3 NSCLC means the cancer has spread to lymph nodes or nearby structures but not to distant organs. Treatment usually involves a combination of therapies, such as chemotherapy and radiation therapy, and sometimes surgery. Dr. Mathangi specializes in multi-modality therapy, using the latest imaging and precision radiation techniques to improve outcomes for stage 3 NSCLC patients.

Can stage 4 NSCLC be treated, and what are the goals of care?

Stage 4 NSCLC, where cancer has spread to distant organs, is generally not curable but can be managed to prolong life and improve quality of life. Treatments may include targeted therapy, immunotherapy, chemotherapy, and palliative radiation therapy. Dr. Mathangi helps patients with stage 4 NSCLC access the latest treatments and clinical trials, focusing on symptom relief and maintaining the best possible quality of life.

What is non squamous lung cancer, and does it affect treatment options?

Non squamous lung cancer refers to NSCLC subtypes that are not squamous cell carcinoma, such as adenocarcinoma and large cell carcinoma. These subtypes often respond differently to certain drugs, especially targeted therapies. Dr. Mathangi conducts thorough molecular testing and tailors treatment plans for non squamous lung cancer, ensuring patients receive the most effective medications for their tumor's genetic makeup.

How does Dr. Mathangi personalize lung cancer treatment for her patients?

Dr. Mathangi uses a multidisciplinary approach and incorporates molecular profiling, advanced imaging, and patient preferences to create individualized treatment plans. Whether it's early-stage surgery, complex radiation therapy, or access to the latest immunotherapies and clinical trials, she ensures every patient with non small lung cancer receives compassionate, evidence-based care tailored to their unique needs.

What support services are available for NSCLC lung cancer patients through Dr. Mathangi's practice?

Beyond medical treatments, Dr. Mathangi’s team offers holistic support including counseling, nutritional advice, pain management, and connections to patient support groups. These services help patients and families cope with the emotional and practical challenges of an NSCLC lung cancer diagnosis and treatment journey.